Zaver M Bhujwalla Selected Research

enhanced green fluorescent protein

1/2019	Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments.
12/2015	Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors.
8/2010	Hypoxic tumor microenvironments reduce collagen I fiber density.
4/2009	Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
1/2008	Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
10/2006	Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zaver M Bhujwalla Research Topics

Disease

122	Neoplasms (Cancer) 06/2022 - 10/2002
52	Breast Neoplasms (Breast Cancer) 06/2022 - 09/2002
27	Hypoxia (Hypoxemia) 12/2020 - 10/2002
22	Neoplasm Metastasis (Metastasis) 12/2021 - 07/2005
14	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 01/2003
7	Triple Negative Breast Neoplasms 12/2021 - 01/2012
5	Cachexia 12/2020 - 11/2011
5	Carcinogenesis 01/2016 - 09/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 03/2016
3	Inflammation (Inflammations) 02/2021 - 03/2017
3	Adenocarcinoma 02/2021 - 11/2011
3	Weight Loss (Weight Reduction) 12/2020 - 11/2011
3	Ovarian Epithelial Carcinoma 01/2018 - 03/2010
2	Acidosis 01/2019 - 11/2003
2	Ascites 01/2016 - 11/2009

Drug/Important Bio-Agent (IBA)

38	Choline (Choline Chloride)IBA 02/2021 - 09/2002
25	EnzymesIBA 06/2022 - 01/2003
22	Choline KinaseIBA 06/2022 - 06/2004
22	Phosphorylcholine (Phosphocholine)IBA 10/2018 - 04/2003
21	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2007
18	Small Interfering RNA (siRNA)IBA 06/2022 - 12/2007
17	Phospholipids (Phosphatides)FDA LinkGeneric 08/2017 - 09/2002
13	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2003
9	ProdrugsIBA 12/2020 - 11/2006
9	LipidsIBA 11/2018 - 11/2011
8	CollagenIBA 01/2020 - 08/2010
7	tdTomatoIBA 01/2019 - 01/2012
7	Contrast MediaIBA 12/2012 - 11/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 11/2002
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2020 - 05/2007
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 12/2007
6	Messenger RNA (mRNA)IBA 01/2020 - 06/2007
6	enhanced green fluorescent proteinIBA 01/2019 - 10/2006
6	Estrogen ReceptorsIBA 12/2016 - 12/2007
6	Biological ProductsIBA 03/2016 - 04/2012
5	AntigensIBA 05/2022 - 09/2015
5	CytokinesIBA 01/2021 - 01/2009
5	Flucytosine (Ancobon)FDA Link 12/2020 - 11/2006
5	Cytosine DeaminaseIBA 12/2020 - 01/2008
5	LuciferasesIBA 12/2020 - 11/2013
5	Protons (Proton)IBA 01/2020 - 12/2004
5	Protein Isoforms (Isoforms)IBA 01/2018 - 07/2010
5	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2016 - 06/2004
5	Indomethacin (Indometacin)FDA LinkGeneric 03/2007 - 09/2002
4	Oxygen (Dioxygen)IBA 01/2019 - 09/2007
4	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 05/2009
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2008 - 11/2002
3	Therapeutic UsesIBA 05/2022 - 01/2008
3	Liposomes (Liposome)IBA 05/2022 - 12/2021
3	LigandsIBA 01/2022 - 05/2010
3	Dextrans (Dextran)FDA Link 01/2020 - 02/2016
3	Red Fluorescent ProteinIBA 01/2019 - 01/2013
3	phospholipase D1IBA 01/2016 - 09/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015 - 09/2007
3	AlbuminsIBA 09/2007 - 01/2003
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2007 - 09/2002
2	Actinium-225IBA 05/2022 - 12/2021
2	Complement System Proteins (Complement)IBA 03/2022 - 10/2016
2	AntibodiesIBA 01/2022 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2008
2	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 02/2017
2	Glutamine (L-Glutamine)FDA Link 12/2020 - 07/2015
2	Ethanolamine (Colamine)IBA 01/2018 - 01/2016
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2018 - 08/2010
2	Conditioned Culture MediaIBA 10/2017 - 04/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 06/2007
2	Lysine (L-Lysine)FDA Link 01/2017 - 06/2008
2	Monoclonal AntibodiesIBA 03/2016 - 06/2003
2	CXCR4 Receptors (CXCR4 Receptor)IBA 03/2016 - 05/2010
2	glycerophosphodiester phosphodiesteraseIBA 01/2016 - 09/2012
2	phosphatidylcholine-specific phospholipase CIBA 01/2016 - 03/2010
2	AntioxidantsIBA 05/2015 - 09/2007
2	Metalloproteases (Metalloproteinases)IBA 01/2015 - 08/2010
2	Collagen Type IV (Type IV Collagen)IBA 01/2014 - 12/2009
2	Peptides (Polypeptides)IBA 01/2014 - 12/2009
2	SodiumIBA 12/2010 - 12/2004
2	AvidinIBA 04/2008 - 06/2003
2	Peptide Hydrolases (Proteases)FDA Link 12/2007 - 07/2005
2	GadoliniumIBA 09/2007 - 06/2003
2	ErbB-2 ReceptorIBA 06/2003 - 03/2003
1	PolyethyleneimineIBA 06/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Cyclic PeptidesIBA 01/2021
1	Protein Disulfide-IsomerasesIBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021

Therapy/Procedure

35	Therapeutics 05/2022 - 10/2002
16	Precision Medicine 06/2022 - 02/2011
9	Drug Therapy (Chemotherapy) 12/2020 - 12/2007
5	Radiotherapy 05/2022 - 08/2012
4	Intravenous Injections 02/2019 - 07/2005
3	Immunotherapy 03/2022 - 02/2019
2	Aftercare (After-Treatment) 08/2017 - 01/2003
2	Intravenous Administration 01/2008 - 03/2007
1	Photochemotherapy (Photodynamic Therapy) 01/2021